Investigation of a Gel Formulation Using a Halobetasol–Phospholipid Complex for Managing the Symptoms of Psoriasis

Journal of Pharmacology and Pharmacotherapeutics · Published 2025-07-09 · DOI 10.1177/0976500x251347400

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/0976500x251347400

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• A Nasal Gel Formulation of Ubrogepant Nanoparticles for Enhanced and Rapid Brain Delivery in the Treatment of Migraine · Journal of Pharmacology and Pharmacotherapeutics · 2025 · Same journal
• Cardiotoxicity Induced by Doxorubicin: Exploring Research Frontiers, Co-word Analysis, Trends, and Thematic Development · Journal of Pharmacology and Pharmacotherapeutics · 2026 · Same journal
• Comparative Evaluation of Peyton’s Four-step Approach and Conventional Teaching Methods for Injection Techniques: A Prospective, Interventional Crossover Study · Journal of Pharmacology and Pharmacotherapeutics · 2026 · Same journal
• Partial Purification and Characterizations of Bacteriocin from Lactobacillus casei Isolated from Goat Milk: A Novel Antimicrobial Agent · Journal of Pharmacology and Pharmacotherapeutics · 2025 · Same journal
• Clinical Frontiers of Exosome Research: A Comprehensive Analysis of Human Trials in Diagnostics, Therapeutics, and Regenerative Medicine · Journal of Pharmacology and Pharmacotherapeutics · 2025 · Same journal
• Medication Adherence Challenges : Factors Influencing Non-Adherence in Saudi Arabia · Journal of Pharmacology and Pharmacotherapeutics · 2026 · Same journal
• Computational Screening of Bioactive Compounds of Gymnema sylvestre for ALR2 Inhibition: A Virtual Screening Approach · Journal of Pharmacology and Pharmacotherapeutics · 2025 · Same journal
• Sociodemographic Factors and Medication Use Among Pulmonary Hypertension Patients at Teaching Hospital Jakarta · Journal of Pharmacology and Pharmacotherapeutics · 2025 · Same journal
• Diabetes Mellitus-related Pathogeny: A Precipitating Factor for Alzheimer’s Disease—An Insight on Repurposing Diabetes Pharmacological Treatments in Alzheimer’s Disease · Journal of Pharmacology and Pharmacotherapeutics · 2025 · Same journal
• Efgartigimod in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Short Communication · Journal of Pharmacology and Pharmacotherapeutics · 2026 · Same journal